Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (131-140 of 215) with videos related to

Pageof 22
Sort By:
Nature Communications|May 18, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J Spencer, Paul F McKay, Sandra Belij-Rammerstorfer, et al.
Vaccine|April 20, 2011
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccineDavid W Porter, Fiona M Thompson, Tamara K Berthoud, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2005
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraDaniel P Webster, Susanna Dunachie, Jenni M Vuola, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2008
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malariaNathan W Schmidt, Rebecca L Podyminogin, Noah S Butler, et al.
Plos One|January 31, 2008
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trialFiona M Thompson, David W Porter, Shinji L Okitsu, et al.
Vaccines|May 18, 2019
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored VaccinePedro M Folegatti, Duncan Bellamy, Rachel Roberts, et al.
Immunity|September 20, 2005
Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infectionMichael Walther, Jon Eric Tongren, Laura Andrews, et al.
Virology Journal|December 6, 2013
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in miceGeorge M Warimwe, Gema Lorenzo, Elena Lopez-Gil, et al.
Vaccines|March 27, 2019
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell LinePedro M Folegatti, Duncan Bellamy, Amy Flaxman, et al.
Research Square|February 23, 2022
Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster modelNeeltje van Doremalen, Jonathan E Schulz, Danielle R Adney, et al.
Pageof 22

Showing results (131-140 of 215) with videos related to

Sort By:
Pageof 22
Nature Communications|May 18, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J Spencer, Paul F McKay, Sandra Belij-Rammerstorfer, et al.
Vaccine|April 20, 2011
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccineDavid W Porter, Fiona M Thompson, Tamara K Berthoud, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2005
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraDaniel P Webster, Susanna Dunachie, Jenni M Vuola, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2008
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malariaNathan W Schmidt, Rebecca L Podyminogin, Noah S Butler, et al.
Plos One|January 31, 2008
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trialFiona M Thompson, David W Porter, Shinji L Okitsu, et al.
Vaccines|May 18, 2019
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored VaccinePedro M Folegatti, Duncan Bellamy, Rachel Roberts, et al.
Immunity|September 20, 2005
Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infectionMichael Walther, Jon Eric Tongren, Laura Andrews, et al.
Virology Journal|December 6, 2013
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in miceGeorge M Warimwe, Gema Lorenzo, Elena Lopez-Gil, et al.
Vaccines|March 27, 2019
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell LinePedro M Folegatti, Duncan Bellamy, Amy Flaxman, et al.
Research Square|February 23, 2022
Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster modelNeeltje van Doremalen, Jonathan E Schulz, Danielle R Adney, et al.
Pageof 22